APA (7th ed.) Citation

A, d. R., B, B., & H, S. (2026). Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies. Drugs, 86(4), 465. https://doi.org/10.1007/s40265-026-02285-2

Chicago Style (17th ed.) Citation

A, du Rand, Buttle B, and Sheppard H. "Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies." Drugs 86, no. 4 (2026): 465. https://doi.org/10.1007/s40265-026-02285-2.

MLA (9th ed.) Citation

A, du Rand, et al. "Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies." Drugs, vol. 86, no. 4, 2026, p. 465, https://doi.org/10.1007/s40265-026-02285-2.